A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 2, 2008, Pages 179-186

  Kazemifard, Amir G ^a   Javadzadeh, Neda ^b   Gholami, Kheirollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

1,4 benzodiazepine; Dissolution tests; HPLC assay; Pharmaceutical dosage forms; Quality control

Indexed keywords

ALPRAZOLAM; AMMONIUM PHOSPHATE; APO FLURAZEPAM; BENZODIAZEPINE DERIVATIVE; BUFFER; CHLORDIAZEPOXIDE; DIAZEPAM; EXCIPIENT; FLURAZEPAM; LORAZEPAM; METHANOL; NITRAZEPAM; NORDAZEPAM; SILANOL;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; DILUTION; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; EXTRACTION; FILTRATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; POWDER; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TABLET; ULTRAVIOLET SPECTROSCOPY;

BENZODIAZEPINES; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; TABLETS;

EID: 45849088782     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rudorfer M.V., Potter W.Z.: Drugs. 37, 713 (1989).
2. Homan R.W., Rosenberg H.C.: The Treatment of Epilepsy, Principles and Practices. p. 932, Lea & Febiger, Philadelphia 1993.
3. File S.E., Pellow S.: Psychotropic Drugs of Abuse. p. 147, Pergamon Press, New York 1990.
4. de Silva J.A.F.: J. Chromatogr. 340, 3 (1985).
5. Berzas J.J., Castaneda G., Pinilla M.J.: Talanta 57, 333 (2002).
6. Abdel-Hamid M.A., Abuirjeie M.A.: Analyst 113, 1443 (1988).
7. Fazzari F.R., Riggleman O.H.: J. Pharm. Sci. 58, 1530 (1969).
8. dos Santos C.M.M., Famila V., Simoes Gonçalves M.L.: Anal. Bioanal. Chem. 374, 1074 (2002).
9. McGrath G., McClean S., O'Kane E. et al.: J. Chromatogr. A 735, 237 (1996).
10. Hida M., Mitsui T., Ohtani H. et al.: J. Pharm. Biomed. Anal. 20, 419 (1999).
11. Spell J.C., Stewart J.T.: J. Pharm. Biomed. Anal. 18, 419 (1998).
12. Roberts S.E., Delaney M.F.: J. Chromatogr. 283, 265 (1984).
13. Perez-Lozano P., Garcia-Montoya E., Orriols A. et al.: J. Pharm. Biomed. Anal. 34, 979 (2004).
14. Lensmeyer G. L., Rajani C., Evenson M.A.: Clin. Chem. 28, 2274 (1982).
15. Berrueta L.A., Gallo B., Vicente F.: J. Pharm. Biomed. Anal. 10, 109 (1992).
16. Bugey A., Staub C.: J. Pharm. Biomed. Anal. 35, 555 (2004).
17. Kazemifard A.G., Dabirsiaghi A., Gholami K. et al.: Acta Pol. Pharm. Drug Res. 64, 481 (2006).
18. United States Pharmacopoeia 29. National Formulary 24, United States Pharmacopoeial Convention, Rockville 2006.
19. ICH Q2B, International Conference on Harmonisation, Validation of Analytical Procedures. Methodology, 1996.
20. Drummer O.H.: J. Chromatogr. B 713, 201 (1998).